United States · FDA National Drug Code directory

Duloxetine D/R

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
72189-615_35ced01c-03fc-4779-e063-6394a90a9cd5
Product NDC
72189-615
Form
CAPSULE, DELAYED RELEASE
Composition / generic term
Duloxetine D/R
Labeler
Direct_Rx
Marketing category
ANDA
Marketing start / end (source format)
20250217
Source listing expiry
20261231

Source-listed ingredients

  • DULOXETINE HYDROCHLORIDE — 30 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72189-615-30) · 72189-615-30
  • 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72189-615-60) · 72189-615-60
  • 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (72189-615-90) · 72189-615-90

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →